• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成途径抑制剂大麻二酚治疗小鼠卵巢过度刺激综合征。

Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor.

机构信息

Endometriosis Research Center, Iran University of Medical Sciences, Tehran, Iran.

Department of Physiology, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.

出版信息

Biomed Res Int. 2022 Dec 21;2022:1111777. doi: 10.1155/2022/1111777. eCollection 2022.

DOI:10.1155/2022/1111777
PMID:36588534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9797301/
Abstract

Studies suggest that ovarian hyperstimulation syndrome (OHSS) can be treated by reducing the level of vascular endothelial growth factor (VEGF). However, due to the side effects of commercially available VEGF-reducing drugs, they can be ruled out as a suitable treatment for OHSS; therefore, researchers are looking for new medications to treat OHSS. This study is aimed at investigating the effects of cannabidiol (CBD) in an OHSS model and to evaluate its efficacy in modulating the angiogenesis pathway and gene expression. For this purpose, 32 female mice were randomly divided into four groups (eight mice per group): control group, group 2 with OHSS induction, group 3 receiving 32 nmol of dimethyl sulfoxide after OHSS induction, and group 4 receiving 30 mg/kg of CBD after OHSS induction. The animals' body weight, ovarian weight, vascular permeability (VP), and ovarian follicle count were measured, and the levels of gene and protein expression in the peritoneal fluid were assessed. Based on the results, CBD decreased the body and ovarian weights, VP, and corpus luteum number compared to the OHSS group ( < 0.05). The peritoneal gene and protein expression levels reduced in the CBD group compared to the OHSS group ( < 0.05). Also, CBD caused OHSS alleviation by suppressing expression and VP. Overall, CBD downregulated gene expression and improved VP in OHSS.

摘要

研究表明,卵巢过度刺激综合征(OHSS)可以通过降低血管内皮生长因子(VEGF)水平来治疗。然而,由于市售的 VEGF 降低药物的副作用,它们不能作为 OHSS 的合适治疗方法;因此,研究人员正在寻找新的药物来治疗 OHSS。本研究旨在探讨大麻二酚(CBD)在 OHSS 模型中的作用,并评估其在调节血管生成途径和基因表达方面的疗效。为此,将 32 只雌性小鼠随机分为四组(每组 8 只):对照组、OHSS 诱导组 2、OHSS 诱导后给予 32nmol 二甲基亚砜的组 3 和 OHSS 诱导后给予 30mg/kg CBD 的组 4。测量动物的体重、卵巢重量、血管通透性(VP)和卵巢卵泡计数,并评估腹腔液中基因和蛋白表达水平。基于结果,与 OHSS 组相比,CBD 降低了体质量和卵巢质量、VP 和黄体数量(<0.05)。与 OHSS 组相比,CBD 组腹腔液中的基因和蛋白表达水平降低(<0.05)。此外,CBD 通过抑制基因表达和 VP 来减轻 OHSS。总体而言,CBD 下调了 OHSS 中的基因表达并改善了 VP。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/882e/9797301/a63c824b1bda/BMRI2022-1111777.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/882e/9797301/fe8abd8717d1/BMRI2022-1111777.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/882e/9797301/55403c2c086e/BMRI2022-1111777.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/882e/9797301/9cbcc407b748/BMRI2022-1111777.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/882e/9797301/e208b8b83787/BMRI2022-1111777.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/882e/9797301/a63c824b1bda/BMRI2022-1111777.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/882e/9797301/fe8abd8717d1/BMRI2022-1111777.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/882e/9797301/55403c2c086e/BMRI2022-1111777.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/882e/9797301/9cbcc407b748/BMRI2022-1111777.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/882e/9797301/e208b8b83787/BMRI2022-1111777.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/882e/9797301/a63c824b1bda/BMRI2022-1111777.005.jpg

相似文献

1
Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor.血管生成途径抑制剂大麻二酚治疗小鼠卵巢过度刺激综合征。
Biomed Res Int. 2022 Dec 21;2022:1111777. doi: 10.1155/2022/1111777. eCollection 2022.
2
Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model.催产素和卡麦角林通过抑制血管内皮生长因子(VEGF)在实验模型中缓解卵巢过度刺激综合征(OHSS)。
Arch Gynecol Obstet. 2021 Apr;303(4):1099-1108. doi: 10.1007/s00404-020-05855-1. Epub 2020 Nov 2.
3
The role of pigment epithelium-derived factor in the pathophysiology and treatment of ovarian hyperstimulation syndrome in mice.色素上皮衍生因子在小鼠卵巢过度刺激综合征的病理生理学和治疗中的作用。
J Clin Endocrinol Metab. 2013 Feb;98(2):E258-66. doi: 10.1210/jc.2012-3037. Epub 2013 Jan 7.
4
Dopamine receptor 2 activation inhibits ovarian vascular endothelial growth factor secretion in an ovarian hyperstimulation syndrome (OHSS) animal model: implications for treatment of OHSS with dopamine receptor 2 agonists.多巴胺受体 2 激动剂抑制卵巢过度刺激综合征(OHSS)动物模型中卵巢血管内皮生长因子的分泌:多巴胺受体 2 激动剂治疗 OHSS 的意义。
Fertil Steril. 2014 Nov;102(5):1468-1476.e1. doi: 10.1016/j.fertnstert.2014.07.1240. Epub 2014 Sep 11.
5
Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model.在大鼠卵巢过度刺激模型中,给予低剂量多巴胺激动剂可阻断血管内皮生长因子(VEGF)介导的血管高通透性,而不改变VEGF受体2依赖性黄体血管生成。
Endocrinology. 2006 Nov;147(11):5400-11. doi: 10.1210/en.2006-0657. Epub 2006 Aug 10.
6
The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.血管内皮生长因子和白细胞介素在重度卵巢过度刺激综合征发病机制中的作用
Hum Reprod Update. 1997 May-Jun;3(3):255-66. doi: 10.1093/humupd/3.3.255.
7
Comparison of montelukast and cabergoline for prevention of ovarian hyperstimulation syndrome: in an experimental rat model.孟鲁司特与卡麦角林预防卵巢过度刺激综合征的比较:在实验大鼠模型中
Gynecol Endocrinol. 2015 May;31(5):369-73. doi: 10.3109/09513590.2014.1000849. Epub 2015 Jan 20.
8
Nintedanib Treatment After Ovulation is an Effective Therapeutic Strategy for the Alleviation of Ovarian Hyperstimulation Syndrome (OHSS) in a Mouse Model.排卵后尼达尼布治疗可有效缓解卵巢过度刺激综合征(OHSS)的小鼠模型。
Drug Des Devel Ther. 2022 Feb 18;16:397-411. doi: 10.2147/DDDT.S351292. eCollection 2022.
9
Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and rec-LH.与 hCG 和 rec-LH 相比,用低分子量 LH 受体激动剂诱导排卵后预防大鼠卵巢过度刺激综合征(OHSS)的发生。
Endocrinology. 2011 Nov;152(11):4350-7. doi: 10.1210/en.2011-1077. Epub 2011 Sep 6.
10
Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study.不同剂量他莫昔芬对卵巢过度刺激综合征患者卵巢组织病理学、血清血管内皮生长因子及内皮素-1水平的影响:一项实验研究
Drug Des Devel Ther. 2015 Mar 24;9:1761-6. doi: 10.2147/DDDT.S75266. eCollection 2015.

引用本文的文献

1
The role of cannabinoid agonists and antagonists on folliculogenesis and evolutionary events in the mouse ovary.大麻素激动剂和拮抗剂在小鼠卵巢卵泡发生及相关进化事件中的作用。
Iran J Basic Med Sci. 2025;28(9):1171-1179. doi: 10.22038/ijbms.2025.85417.18468.
2
The impact of cannabinoids on reproductive function.大麻素对生殖功能的影响。
Reproduction. 2025 Apr 3;169(5). doi: 10.1530/REP-24-0369. Print 2025 May 1.
3
Effect of EMB-FUBINACA on brain endothelial cell angiogenesis: Expression analysis of angiogenic markers.依替米星-富马酸福莫特罗对脑内皮细胞血管生成的影响:血管生成标志物的表达分析

本文引用的文献

1
Molecular and Biochemical Mechanism of Cannabidiol in the Management of the Inflammatory and Oxidative Processes Associated with Endometriosis.大麻二酚在子宫内膜异位症相关炎症和氧化过程管理中的分子和生化机制。
Int J Mol Sci. 2022 May 12;23(10):5427. doi: 10.3390/ijms23105427.
2
Oxytocin and cabergoline alleviate ovarian hyperstimulation syndrome (OHSS) by suppressing vascular endothelial growth factor (VEGF) in an experimental model.催产素和卡麦角林通过抑制血管内皮生长因子(VEGF)在实验模型中缓解卵巢过度刺激综合征(OHSS)。
Arch Gynecol Obstet. 2021 Apr;303(4):1099-1108. doi: 10.1007/s00404-020-05855-1. Epub 2020 Nov 2.
3
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb;398(2):1613-1624. doi: 10.1007/s00210-024-03322-1. Epub 2024 Aug 13.
Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals?
大麻二酚及其他非精神活性大麻素用于预防和治疗胃肠道疾病:有益的营养保健品?
Int J Mol Sci. 2020 Apr 26;21(9):3067. doi: 10.3390/ijms21093067.
4
Antioxidative and Anti-Inflammatory Properties of Cannabidiol.大麻二酚的抗氧化和抗炎特性
Antioxidants (Basel). 2019 Dec 25;9(1):21. doi: 10.3390/antiox9010021.
5
Vasodilatory effects of cannabidiol in human pulmonary and rat small mesenteric arteries: modification by hypertension and the potential pharmacological opportunities.大麻二酚对人肺和大鼠小肠系膜动脉的舒张作用:高血压的修饰作用和潜在的药理学机会。
J Hypertens. 2020 May;38(5):896-911. doi: 10.1097/HJH.0000000000002333.
6
Cannabidiol-from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer.大麻二酚:从植物到人体——一种具有多靶点效应的有前景的生物活性分子,对癌症有作用。
Int J Mol Sci. 2019 Nov 25;20(23):5905. doi: 10.3390/ijms20235905.
7
Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment.大麻二酚:神经精神疾病治疗的最新进展和新见解。
Life Sci. 2019 May 1;224:120-127. doi: 10.1016/j.lfs.2019.03.053. Epub 2019 Mar 22.
8
Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination.大麻及其次生代谢产物:它们作为治疗药物的用途、毒理学方面以及分析测定
Medicines (Basel). 2019 Feb 23;6(1):31. doi: 10.3390/medicines6010031.
9
Cannabidiol's Upregulation of -acyl Ethanolamines in the Central Nervous System Requires -acyl Phosphatidyl Ethanolamine-Specific Phospholipase D.大麻二酚在中枢神经系统中上调酰基乙醇胺需要酰基磷脂酰乙醇胺特异性磷脂酶D。
Cannabis Cannabinoid Res. 2018 Nov 30;3(1):228-241. doi: 10.1089/can.2018.0031. eCollection 2018.
10
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.大麻中的大麻素、萜烯和类黄酮的药用特性,以及在偏头痛、头痛和疼痛方面的益处:当前证据和大麻科学的更新。
Headache. 2018 Jul;58(7):1139-1186. doi: 10.1111/head.13345.